Corresponding results were, for CDH1 (1 tumor with mean >10% and 1 additional tumor with max at 17%), for RASSF2 (1 tumor + 24 tumors up to 15%), for DCR2 (5 tumors + 3 tumors up to 39%), for RASSF1A (23 tumors + 1 up to 31%), and for CASP8 A1 (21 tumors + 2 tumors up to 21%). The gene discussed is RASSF1; the disease is neoplasm.